Activity-dependent neurotrophic factor: Intranasal administration of femtomolar-acting peptides improve performance in a water maze

Keyphrases

• Performance Improvement 100%
• Neurotrophic Factors 100%
• Activity-dependent 100%
• Femtomolar 100%
• Water Maze 100%
• Intranasal Administration 100%
• Factor 9 63%
• Glia 18%
• Pharmacokinetics 9%
• Neurodegeneration 9%
• Neuroprotection 9%
• Rodent Models 9%
• Treatment Cessation 9%
• Derived Peptide 9%
• Cholinotoxin 9%
• Choline Acetyltransferase (ChAT) 9%
• Drug Design 9%
• Non-invasive Administration 9%
• Route of Administration 9%
• Learning Development 9%
• Neuroprotective 9%
• Learning Impairment 9%
• Femtomolar Concentration 9%
• Neuronal Apoptosis 9%
• Neurotoxin 9%
• Apolipoprotein E Knockout Mice 9%
• Cultured Neurons 9%
• Fetal Growth Retardation 9%
• Better Performance 9%
• Low Dosage 9%
• Short-term Spatial Memory 9%
• Amino Acids/peptides 9%

Neuroscience

• Neurotrophic Factor 100%
• Water Maze 100%
• Peptide 100%
• Factor IX 63%
• Glia 18%
• Neurodegeneration 9%
• Neuroprotective Agent 9%
• Neuroprotection 9%
• Arginine 9%
• Amino Acid 9%
• Neuroapoptosis 9%
• Neurotoxin 9%
• Leucylserylalanylleucine 9%
• Apolipoprotein E 9%
• Choline Acetyltransferase 9%
• Learning Disabilities 9%
• Pharmacokinetics 9%
• Spatial Memory 9%